Literature DB >> 1774375

Cognitive-behavioral stress management intervention buffers distress responses and immunologic changes following notification of HIV-1 seropositivity.

M H Antoni1, L Baggett, G Ironson, A LaPerriere, S August, N Klimas, N Schneiderman, M A Fletcher.   

Abstract

Forty-seven asymptomatic, healthy gay men were randomly assigned to a cognitive-behavioral stress management (CBSM) condition or an assessment-only control group 5 weeks before being notified of their HIV-1 antibody status. Seventy-two hours before and 1 week after serostatus notification, blood samples and psychometric data were collected. Control subjects showed significant increases in depression, but only slight decrements in mitogen responsivity and lymphocyte cell counts pre- to postnotification of seropositivity. Seropositive CBSM Ss did not show significant pre-post changes in depression, but did reveal significant increases in helper-inducer (CD4) and natural killer (CD56) cell counts as well as a slight increment in proliferative responses to phytohemagglutinin (PHA). Individual difference analyses suggest that the psychological buffering and immunomodulating effects of the CBSM manipulation may be attributable, in part, to relaxation skills learned and practiced or to a general willingness to comply with the intervention guidelines.

Entities:  

Mesh:

Year:  1991        PMID: 1774375     DOI: 10.1037//0022-006x.59.6.906

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  51 in total

1.  Reductions in salivary cortisol are associated with mood improvement during relaxation training among HIV-seropositive men.

Authors:  D G Cruess; M H Antoni; M Kumar; N Schneiderman
Journal:  J Behav Med       Date:  2000-04

2.  Positive emotions: exploring the other hemisphere in behavioral medicine.

Authors:  Margaret A Chesney; Lynae A Darbes; Kate Hoerster; Jonelle M Taylor; Donald B Chambers; David E Anderson
Journal:  Int J Behav Med       Date:  2005

Review 3.  Future directions for interventions targeting PTSD in HIV-infected adults.

Authors:  Allison J Applebaum; C Andres Bedoya; Ellen S Hendriksen; Jesse L Wilkinson; Steven A Safren; Conall O'Cleirigh
Journal:  J Assoc Nurses AIDS Care       Date:  2014-11-10       Impact factor: 1.354

4.  Cognitive behavioral stress management intervention improves quality of life in Spanish monolingual hispanic men treated for localized prostate cancer: results of a randomized controlled trial.

Authors:  Frank J Penedo; Lara Traeger; Jason Dahn; Ivan Molton; Jeffrey S Gonzalez; Neil Schneiderman; Michael H Antoni
Journal:  Int J Behav Med       Date:  2007

Review 5.  Stress and health: psychological, behavioral, and biological determinants.

Authors:  Neil Schneiderman; Gail Ironson; Scott D Siegel
Journal:  Annu Rev Clin Psychol       Date:  2005       Impact factor: 18.561

6.  Psychoneuroimmunology examined: The role of subjective stress.

Authors:  Lisa M Thornton; Barbara L Andersen
Journal:  Cellscience       Date:  2006-04-30

7.  The combined effect of relaxation response and acupuncture on quality of life in patients with HIV: a pilot study.

Authors:  Bei-Hung Chang; Ulrike Boehmer; Yue Zhao; Elizabeth Sommers
Journal:  J Altern Complement Med       Date:  2007-10       Impact factor: 2.579

8.  Mind-Body Medicine and Immune System Outcomes: A Systematic Review.

Authors:  Helané Wahbeh; Ashley Haywood; Karen Kaufman; Heather Zwickey
Journal:  Open Complement Med J       Date:  2009

9.  Mental health treatment to reduce HIV transmission risk behavior: a positive prevention model.

Authors:  Kathleen J Sikkema; Melissa H Watt; Anya S Drabkin; Christina S Meade; Nathan B Hansen; Brian W Pence
Journal:  AIDS Behav       Date:  2010-04

10.  Stress Management, Depression and Immune Status in Lower Income Racial/Ethnic Minority Women Co-infected with HIV and HPV.

Authors:  Corina R Lopez; Michael H Antoni; Deirdre Pereira; Julia Seay; Nicole Whitehead; Jonelle Potter; Maryjo O'Sullivan; Mary Ann Fletcher
Journal:  J Appl Biobehav Res       Date:  2013-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.